Skip to main content
ETON filings

Corporate insider profile

Sean Brynjelsen Filing Activity

Latest reported as President & CEO of Eton Pharmaceuticals, Inc. (ETON).

Purchase filings
0
Reported companies
1
Net open-market value
-$3,825,720.00
Latest transaction
May 28, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
May 28, 2026Eton Pharmaceuticals, Inc. (ETON)President & CEOSale120,000$31.88$3,825,720